CIAM
BRTX icon

Caitong International Asset Management’s BioRestorative Therapies BRTX Stock Holding History

Caitong International Asset Management’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 3028
2026
Q1 		$0 Buy
+1
New +$1 ﹤0.01% 2640

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Caitong International Asset Management's BRTX Position: Q2 2026 in Review

Caitong International Asset Management held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

Caitong International Asset Management first reported a position in BRTX in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Caitong International Asset Management held 1 share of BioRestorative Therapies worth $0 as of Q2 2026.
  • Caitong International Asset Management left its BioRestorative Therapies share count unchanged in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #3028 holding.
  • Caitong International Asset Management first reported a position in BioRestorative Therapies in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.